ロード中...
KRAS mutation testing in the treatment of metastatic colorectal cancer with anti-EGFR therapies
Survival of patients with metastatic CRC (mCRC) has improved steadily over the past several decades, due largely to the development of new combinations of standard chemotherapy, as well as to the introduction of new targeted therapies. Among the available targeted therapies are two monoclonal antibo...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Multimed Inc.
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2901795/ https://ncbi.nlm.nih.gov/pubmed/20680106 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|